Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics
February 25, 2026
8PM ET
As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life. This webinar brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications.
Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.
